Otonomy to Participate in Two Upcoming Investor Conferences
September 02 2021 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that management is scheduled to
participate in two upcoming virtual conferences:
- H.C. Wainwright 23rd Annual Global
Investment Conference: a pre-recorded fireside chat will be
available on-demand starting at 7 a.m. ET / 4 a.m. PT on September
13, 2021;
- Cantor Global Healthcare
Conference: presentation on September 29, 2021 at 2:40 p.m. ET /
11:40 a.m. PT.
The pre-recorded H.C. Wainwright presentation and the live audio
webcast and archived replay of the Cantor presentation will be
available through the Events page of the company's website
(www.otonomy.com).
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs with a focus on hearing loss and tinnitus. For
additional information, please visit www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Oct 2023 to Oct 2024